Yang M, Liu K, Chen P, Zhu H, Wang J, Huang J
Liraglutide, a oncedaily human GLP1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD1 SU)
It can be very concerning, too, if you have an eating disorder such as anorexia, bulimia or orthorexia, and you start on a GLP-1
Tirzepatide Highest Dose: Side Effect Profile and Management At the 15mg tirzepatide highest dose, gastrointestinal adverse events remain the primary tolerability concern
Traditional oral glutathione is poorly absorbed because it gets broken down in the digestive tract before reaching cells
But misuse of IGF-1 in sports is a big concern and we need to develop effective detection methods to prevent abuse and ensure fair competition